Sihuan Biotech announced that the company plans to acquire 65.6146% of Zhongrun Pharmaceutical's shares for RMB 160 million in cash, of which Zhongrun Pharmaceutical will transfer 63.5963% and Guangdong Kunhai will transfer 2.0183%; at the same time, Zhongrun Pharmaceutical will target capital cuts to Guangdong Kunhai and Guangdong Purun by a total of 17.9817%. After the transaction is completed and the capital is reduced, the company will hold 80% of Zhongrun Pharmaceutical's shares. The transaction has been reviewed and approved by the board of directors and still needs to be submitted to the shareholders' meeting for consideration.

Sihuan Biotech announced that the company plans to acquire 65.6146% of Zhongrun Pharmaceutical's shares for RMB 160 million in cash, of which Zhongrun Pharmaceutical will transfer 63.5963% and Guangdong Kunhai will transfer 2.0183%; at the same time, Zhongrun Pharmaceutical will target capital cuts to Guangdong Kunhai and Guangdong Purun by a total of 17.9817%. After the transaction is completed and the capital is reduced, the company will hold 80% of Zhongrun Pharmaceutical's shares. The transaction has been reviewed and approved by the board of directors and still needs to be submitted to the shareholders' meeting for consideration.